Search Results for 'manager of Medical Technologies Division'

Medtronic plc, a global leader in medical technology, services and solutions, this week announced a new manufacturing facility in Galway that will manufacture the market-leading IN.PACT® Admiral® drug-coated balloon (DCB) for the treatment of peripheral artery disease (PAD). PAD is a build-up of plaque in arteries throughout the body leading to reduced blood flow to the limbs, organs, and the brain. Patients with PAD are at higher risk for stroke and heart attack.

Global medical technology company Medtronic’s has announced it will construct a new manufacturing facility in Galway, that will manufacture the IN.PACT Admiral drug-coated balloon for the treatment of peripheral artery disease.